{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:15:23Z","timestamp":1783185323764,"version":"3.54.6"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jocn.2019.05.035","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T18:46:43Z","timestamp":1560278803000},"page":"163-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Cephalosporin-related neurotoxicity: Metabolic encephalopathy or non-convulsive status epilepticus?"],"prefix":"10.1016","volume":"67","author":[{"given":"James D.","family":"Triplett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D.","family":"Lawn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2019.05.035_b0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0987-7053(00)00234-3","article-title":"Severe but reversible encephalopathy associated with cefepime","volume":"30","author":"Jallon","year":"2000","journal-title":"Neurophysiol Clin"},{"key":"10.1016\/j.jocn.2019.05.035_b0010","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1528-1167.2005.16305.x","article-title":"Cephalosporin-induced nonconvulsive status epilepticus: Clinical and electroencephalographic features","volume":"46","author":"Fern\u00e1ndez-Torre","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2019.05.035_b0015","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1684\/epd.2013.0614","article-title":"Usefulness of bilateral bispectral index (BIS) monitoring in a comatose patient with myoclonic status epilepticus secondary to cefepime","volume":"15","author":"Fern\u00e1ndez-Torre","year":"2013","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.jocn.2019.05.035_b0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yebeh.2015.04.034","article-title":"Drug-induced status epilepticus","volume":"49","author":"Cock","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jocn.2019.05.035_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000002455","article-title":"Antibiotic-associated encephalopathy","volume":"86","author":"Bhattacharyya","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2019.05.035_b0030","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/WNL.0000000000002023","article-title":"Seizures as adverse events of antibiotic drugs: a systematic review","volume":"85","author":"Sutter","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2019.05.035_b0035","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0028-3908(03)00188-6","article-title":"Evidence for the involvement of GABA (A) receptor blockade in convulsions induced by cephalosporins","volume":"45","author":"Sugimoto","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jocn.2019.05.035_b0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ebcr.2016.04.005","article-title":"Nonconvulsive status epilepticus cases arising in connection with cephalosporins","volume":"6","author":"Bora","year":"2016","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1016\/j.jocn.2019.05.035_b0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1017\/S0317167100004935","article-title":"Triphasic waves versus non-convulsive status epilepticus: EEG distinction","volume":"33","author":"Boulanger","year":"2006","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.jocn.2019.05.035_b0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/WNP.0000000000000151","article-title":"Affair with triphasic waves \u2013 their striking presence, mysterious significance, and cryptic origins: What are they?","volume":"32","author":"Kaplan","year":"2015","journal-title":"J Clin Neurophsyiol"},{"issue":"S6","key":"10.1016\/j.jocn.2019.05.035_b0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/epi.12270","article-title":"Unified EEG terminology and criteria for nonconvulsive status epilepticus","volume":"54","author":"Beniczky","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2019.05.035_b0060","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus \u2013 report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.jocn.2019.05.035_b0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1684\/epd.2016.0867","article-title":"Varied responses to benzodiazepine treatment in cephalosporin-related generalized periodic discharges","volume":"18","author":"Liu","year":"2016","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.jocn.2019.05.035_b0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(01)00767-7","article-title":"Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure","volume":"111","author":"Martinez-Rodriguez","year":"2001","journal-title":"Am J Med"},{"issue":"S8","key":"10.1016\/j.jocn.2019.05.035_b0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1528-1167.2007.01344.x","article-title":"What is nonconvulsive status epilepticus and what are its subtypes?","volume":"48","author":"Shorvon","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2019.05.035_b0080","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/WNP.0b013e31826bde70","article-title":"Comparison of triphasic waves and epileptic discharges in one patient with genetic epilepsy","volume":"29","author":"Kaplan","year":"2012","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.jocn.2019.05.035_b0085","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00004691-200107000-00006","article-title":"Effects of benzodiazepines on triphasic waves: Implications for nonconvulsive status epilepticus","volume":"18","author":"Fountain","year":"2001","journal-title":"J Clin Neurophysiol"},{"issue":"4","key":"10.1016\/j.jocn.2019.05.035_b0090","first-page":"ofx170","article-title":"Characterizing cefepime neurotoxicity: a systematic review. Open forum","volume":"4","author":"Appa","year":"2017","journal-title":"Infect Dis."},{"key":"10.1016\/j.jocn.2019.05.035_b0095","unstructured":"Maxipime (cefepime hydrochloride, USP) for injection for intravenous or intramuscular use prescribing information. Elan. South San Francisco, CA; 2009 Mar. Accessed January 2019."},{"key":"10.1016\/j.jocn.2019.05.035_b0100","unstructured":"Micromedex Healthcare Series [Internet database]. Greenwood Village, CO: Thomson Reuters (Healthcare), Inc. Available at http:\/\/www.thomsonhc.com\/hcs\/librarian. Accessed April 2018"},{"key":"10.1016\/j.jocn.2019.05.035_b0105","unstructured":"Rochephin (Ceftriaxone sodium) for injection for intravenous or intramuscular use prescribing information. Roche. Nutley, New Jersey. Accessed January 2019."}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586818313079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586818313079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:18:48Z","timestamp":1760822328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586818313079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":21,"alternative-id":["S0967586818313079"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2019.05.035","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cephalosporin-related neurotoxicity: Metabolic encephalopathy or non-convulsive status epilepticus?","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2019.05.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}